I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 2.54% to $139.70 on Monday, underperforming competitors like Eli Lilly and Johnson & Johnson during a broader market decline. The stock experienced its second consecutive day of losses, trading at 60.63% below its 52-week high. Trading volume reached 1.9 million, exceeding the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slid 2.54% to $139.70 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.
This was the stock's second consecutive day of losses.
Insulet Corp. closed 60.63% short of its 52-week high of $354.88, which the company reached on November 20th.
The stock underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. (LLY) rose 0.25% to $1,183.16, DexCom Inc. (DXCM) fell 1.10% to $88.76, and Johnson & Johnson (JNJ) rose 0.78% to $262.37.
Trading volume (1.9 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-17-26 1718ET